Skip to main content

Table 1 Characters of the studied patients.

From: Occult hepatitis B infection in egyptian chronic hepatitis C patients: prevalence, impact on pegylated interferon/ribavirin therapy

Number

155

Age(years)

  

X- ± SD

41.8 ± 9.2

Range

19-59

Sex

  

M

125

80.6%

F

30

19.4%

BMI

  

X- ± SD

27.3 ± 3.6

Range

21- 40.5

Duration of HCV infection (years)

  

X- ± SD

4.4 ± 3.6

Range

1-19

Smoking status

  

Non

81

52.2%

Active

57

36.8%

Ex-smoker

17

11.0%

Basal ALT (× ULN)

  

≤2

116

74.8%

> 2

39

25.2%

Basal AST (× ULN)

  

≤ 2

124

80%

> 2

31

20%

Activity

  

1

52

33.6%

2

71

45.8%

3

32

20.6%

Fibrosis

  

1

54

34.8%

2

61

39.4%

3

36

23.2%

4

4

2.6%

Basal HCV Viral Load (IU × 105)

  

X- ± SD

3.87 ± 5.7

Range

0.001-22.3